Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

FRONT Block for Quality of Recovery After Total Hip Arthroplasty

NCT07458360 · tracked via the Priya Life Science Turkey tracker
Sponsor
Konya Meram State Hospital
Phase
Not applicable
Started
2026-04-25
Last updated
2026-09-28

Condition(s) studied

Osteoarthritis of the HipPostoperative PainQuality of Recovery

Investigational drug(s) / intervention(s)

FRONT Block (Femoral Rami and Obturator Nerve Trunk Block)Standard Multimodal Analgesia

FRONT Block (Femoral Rami and Obturator Nerve Trunk Block): Ultrasound-guided unilateral FRONT block targeting the femoral rami and obturator nerve trunk will be performed

Standard Multimodal Analgesia: Standardized postoperative multimodal analgesia including intravenous paracetamol, nonsteroidal anti-inflammatory drugs, and rescue opioid analgesia as required.

Study summary

This prospective randomized controlled trial evaluates the effect of ultrasound-guided unilateral Femoral Rami and Obturator Nerve Trunk (FRONT) block on postoperative quality of recovery in patients undergoing elective total hip arthroplasty.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥ 18 years * Scheduled for total hip arthroplasty under spinal anesthesia * American Society of Anesthesiologists (ASA) physical status I-III * Ability to understand and complete the QoR-15 questionnaire * Provided written informed consent Exclusion Criteria: * Refusal to participate * Contraindication to spinal anesthesia or regional block * Allergy to study medications * Chronic opioid use (daily use for more than 3 months) * Neurological or neuromuscular disorders affecting the lower extremities * Infection at the injection site * Coagulation disorders * Cognitive impairment prevents questionnaire completion

Primary outcome measure(s)

  • Postoperative Quality of Recovery (QoR-15 Score) — 24 hours after surgery
    Postoperative quality of recovery will be assessed using the validated Quality of Recovery-15 (QoR-15) questionnaire. The total score ranges from 0 to 150, with higher scores indicating better recovery.

Trial sites (1)

FacilityCityRegionStatus
Betul Kozanhan Konya Turkey (Türkiye) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07458360 on ClinicalTrials.gov ↗ ← All trials in Turkey